Exopharm’s Big Idea Heading For A Big Business In EV Medicines

“As a serial biotechnology entrepreneur, Dr Dixon doesn’t just develop technologies or products – he wants to build long-lasting businesses based upon big ideas.”

Written by our Chief Commercial Officer Chris Baldwin, this Sharecafe article explains Dr Dixon’s big idea back in 2013 and how it led to the foundation of Exopharm. Today, Exopharm is at the forefront of this emerging field worldwide and the only listed pure-play exosome company on the ASX.

You can access the full article here.